Phase II Clinical Trial of CNCT19 Cell Injection in the Treatment of Relapsed or Refractory Non-Hodgkin's Lymphoma
Conditions
Non-Hodgkin's Lymphoma
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Beijing Boren Hospital, Beijing, Beijing Municipality, China
Contact: Study coordinator (Kai Hu, Dr.)Beijing Cancer Hospital, Beijing, Beijing Municipality, China
Contact: Study coordinator (Yuqin Song, Dr.)Peking University Third Hospital, Beijing, Beijing Municipality, China
Contact: Study coordinator (Hongmei Jing, Dr.)The First Affiliated Hospital of Chongqing Medical University, Chongqing, Chongqing Municipality, China
Contact: Study coordinator (Lin Liu, Dr.)Xinqiao Hospital of TMMU, Chongqing, Chongqing Municipality, China
Contact: Study coordinator (Li Gao, Dr.)Guangdong Provincial Peoples' Hospital, Guangzhou, Guangdong, China
Contact: Study coordinator (Wenyu Li, Dr.)SunYat-Sen University Cancer Center, Guangzhou, Guangdong, China
Contact: Study coordinator (Huiqing Huang, Dr.)Henan Cancer Hospital, Zhengzhou, Henan, China
Contact: Study coordinator (Keshu Zhou, Dr.)The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China
Contact: Study coordinator (Mingzhi Zhang, Dr.)Tongji Hospital, Tongji Medical College of HUST, Wuhan, Hubei, China
Contact: Study coordinator (Liang Huang, Dr.)Qilu Hospital of Shandong University, Jinan, Shandong, China
Contact: Study coordinator (Chunyan Ji, Dr.)Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, Shanghai Municipality, China
Contact: Study coordinator (Weili Zhao, Dr.)Tongji Hospital of Tongji University, Shanghai, Shanghai Municipality, China
Contact: Study coordinator (Aibin Liang, Dr.)West China Hospital，Sichuan University, Chengdu, Sichuan, China
Contact: Study coordinator (Ting Niu, Dr.)Institute of Hematology & Blood Diseases Hospital, Tianjin, Tianjin Municipality, China
Contact: Study coordinator (Dehui Zou, Dr.)Tianjin Medical University Cancer Institute & Hospital, Tianjin, Tianjin Municipality, China
Contact: Study coordinator (Lanfang Li, Dr.)The First Affiliated Hospital, Zhejiang University school of Medicine, Hangzhou, Zhejiang, China
Contact: Study coordinator (Jie Jin, Dr.)
Study leads
Dehui Zou, Dr.
Principal Investigator
Institute of Hematology & Blood Diseases Hospital, China
Weili Zhao, Dr.
Principal Investigator
Ruijin Hospital